These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8173699)

  • 21. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic experience with cilazapril.
    Rosenthal JH
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S65-9. PubMed ID: 7898097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cilazapril prevents hypertension in spontaneously hypertensive rats.
    Hefti F; Fischli W; Gerold M
    J Cardiovasc Pharmacol; 1986; 8(3):641-8. PubMed ID: 2425185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal abnormalities in nonmodulating essential hypertension.
    Williams GH; Moore TJ; Hollenberg NK
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress.
    Schmieder RE; Schobel HP; Gatzka CE; Häuser W; Dominiak P; Mann JF; Luft FC
    J Hypertens; 1996 Oct; 14(10):1201-7. PubMed ID: 8906519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension.
    Belz GG; Breithaupt K; Erb K; Kleinbloesem CH; Wolf GK
    J Hypertens; 1989 Oct; 7(10):817-24. PubMed ID: 2531184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and efficacy of antihypertensive treatment with cilazapril in general practice.
    Rosenthal JR; Osowski U
    Cardiology; 1996; 87(1):54-9. PubMed ID: 8631045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.
    Michel JB; Dussaule JC; Choudat L; Auzan C; Nochy D; Corvol P; Menard J
    Kidney Int; 1986 May; 29(5):1011-20. PubMed ID: 3014201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
    Weir MR; Chrysant SG; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Lewin AJ; Mennella RF; Kirkegaard LW; Hamilton JH; Weinberger MH; Weder AB
    Hypertension; 1998 May; 31(5):1088-96. PubMed ID: 9576119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of coronary blood flow reserve by 13N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril).
    Masuda D; Nohara R; Tamaki N; Hosokawa R; Inada H; Hikai T; Chen LG; Tadamura E; Kudou T; Konishi J; Fujita M; Sasayama S
    Ann Nucl Med; 2000 Oct; 14(5):353-60. PubMed ID: 11108164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril.
    Kirch W; Stroemer K; Hoogkamer JF; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):297S-301S. PubMed ID: 2527542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?
    Erb KA; Breithaupt K; Kleinbloesem CH; Wolf GK; Belz GG
    Clin Physiol Biochem; 1990; 8 Suppl 2():35-45. PubMed ID: 2151315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a very-low-dose combination of perindopril and indapamide--preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control--a randomized, double-blind, add-on study.
    Sung SH; Wu TC; Lin SJ; Chen JW
    J Chin Med Assoc; 2008 May; 71(5):247-53. PubMed ID: 18490229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.